MESCHIARI, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.281
EU - Europa 6.751
AS - Asia 6.637
SA - Sud America 1.070
AF - Africa 191
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.969
IT - Italia 2.660
SG - Singapore 2.134
CN - Cina 1.593
GB - Regno Unito 1.184
VN - Vietnam 839
HK - Hong Kong 760
BR - Brasile 745
DE - Germania 529
SE - Svezia 509
RU - Federazione Russa 362
FI - Finlandia 349
FR - Francia 307
KR - Corea 232
NL - Olanda 206
CA - Canada 188
ID - Indonesia 187
IN - India 176
AR - Argentina 112
TR - Turchia 96
BD - Bangladesh 94
BG - Bulgaria 83
MX - Messico 76
ES - Italia 74
UA - Ucraina 66
LT - Lituania 65
JP - Giappone 63
ZA - Sudafrica 63
IQ - Iraq 57
PL - Polonia 57
CO - Colombia 54
IR - Iran 53
CL - Cile 44
EC - Ecuador 44
PK - Pakistan 41
AE - Emirati Arabi Uniti 40
IE - Irlanda 40
AT - Austria 35
CZ - Repubblica Ceca 34
MY - Malesia 34
SI - Slovenia 33
MA - Marocco 30
BE - Belgio 27
TH - Thailandia 27
AU - Australia 24
CH - Svizzera 22
SA - Arabia Saudita 22
JO - Giordania 21
PH - Filippine 21
VE - Venezuela 21
UZ - Uzbekistan 19
RO - Romania 16
EG - Egitto 15
KZ - Kazakistan 15
NP - Nepal 15
PY - Paraguay 15
IL - Israele 14
PE - Perù 14
TN - Tunisia 14
GR - Grecia 13
DO - Repubblica Dominicana 12
BO - Bolivia 11
KE - Kenya 11
DZ - Algeria 10
TW - Taiwan 10
AZ - Azerbaigian 9
PS - Palestinian Territory 9
AL - Albania 8
CR - Costa Rica 8
HU - Ungheria 8
LV - Lettonia 8
SN - Senegal 8
UY - Uruguay 8
BH - Bahrain 7
GE - Georgia 7
JM - Giamaica 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
DK - Danimarca 6
NG - Nigeria 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
ET - Etiopia 5
MD - Moldavia 5
CI - Costa d'Avorio 4
CY - Cipro 4
EE - Estonia 4
MK - Macedonia 4
NO - Norvegia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BF - Burkina Faso 3
BZ - Belize 3
CG - Congo 3
EU - Europa 3
GA - Gabon 3
HR - Croazia 3
Totale 24.900
Salva come PNG Salva come JPEG
Città #
Ashburn 1.393
Singapore 1.368
Santa Clara 1.286
Fairfield 779
Hong Kong 737
Southend 653
Chandler 638
San Jose 596
Hefei 535
Nyköping 333
Woodbridge 303
Houston 292
Cambridge 291
London 282
Ho Chi Minh City 273
Seattle 271
Helsinki 268
Beijing 253
Los Angeles 237
New York 229
Seoul 223
Council Bluffs 213
Wilmington 212
Modena 191
Hanoi 184
Bologna 179
Dallas 171
Rome 171
Milan 165
Munich 165
Jakarta 150
Chicago 149
San Diego 138
The Dalles 116
Ann Arbor 114
Lauterbourg 100
Shanghai 95
Moscow 91
Princeton 76
São Paulo 71
Sofia 70
Frankfurt am Main 67
Toronto 67
Buffalo 61
Parma 59
Bremen 55
Amsterdam 51
Orem 51
Naples 50
Tokyo 50
Warsaw 47
Turku 46
Da Nang 45
Jacksonville 45
Dearborn 43
Hillsboro 39
Atlanta 38
Boardman 38
Paris 38
Montreal 37
North York 37
Redwood City 36
Reggio Emilia 36
Palermo 34
Salt Lake City 34
Fremont 33
Johannesburg 31
Phoenix 31
Stockholm 31
Nuremberg 30
Dublin 29
Kent 28
Redondo Beach 28
Turin 28
Chennai 27
Rio de Janeiro 27
Haiphong 26
Mexico City 26
Brooklyn 25
Catania 25
Denver 25
Florence 25
Mumbai 25
Poplar 25
Madrid 24
Lappeenranta 23
Santiago 23
Brussels 22
Portsmouth 22
Belo Horizonte 21
Des Moines 21
Grafing 21
Izmir 21
Rimini 21
Verona 21
Bari 20
Biên Hòa 20
Columbus 20
Dong Ket 20
Guangzhou 20
Totale 16.030
Salva come PNG Salva come JPEG
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 789
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 645
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 523
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 453
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 447
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 434
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 428
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 395
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 379
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 367
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 362
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 362
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 355
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 341
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 332
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 330
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 330
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 327
Ectopic fat is linked to prior cardiovascular events in men with HIV. 326
Hypokalemia in Patients with COVID-19 309
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 299
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 295
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 287
Peritoneal dialysis in the time of coronavirus disease 2019 285
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 279
Metabolic reprograming shapes neutrophil functions in severe COVID-19 274
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 267
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 265
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 264
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 261
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 255
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 247
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 245
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 244
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 244
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 244
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 241
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 239
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 237
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 234
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 233
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 232
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 230
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 229
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 227
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 226
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 225
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 222
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 220
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 218
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 214
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 210
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 208
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 207
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 206
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 202
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 200
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 198
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 195
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 193
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 193
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 192
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 189
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 188
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 186
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 186
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 185
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 183
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 180
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 177
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 177
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 166
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 165
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 165
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 159
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 158
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 157
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 155
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 155
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 151
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 151
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 150
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 146
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study project 146
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 145
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 143
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 141
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 137
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 131
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 130
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 129
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 128
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 124
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 121
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Horse Rider Patient: A Case Report and Literature Review 118
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 116
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 112
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 110
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 106
Totale 24.191
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021613 0 0 0 0 0 0 0 0 0 171 249 193
2021/20222.228 149 141 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/20255.528 198 120 133 389 909 874 444 328 610 312 551 660
2025/20269.604 822 503 897 1.225 1.407 589 1.338 592 1.117 1.114 0 0
Totale 25.221